Prader-Willi Syndrome children's autistic and sensory profiles investigated; early oxytocin impact analyzed.

Prader-Willi Syndrome (PWS) is a rare neurodevelopmental disorder caused by genetic damage in the 15q11-q13 region, leading to hypothalamic dysfunction. This results in significant challenges including social interaction deficits, intellectual impairments, severe eating disorders, mood disturbances, and sensory-related autistic features. Despite PWS being recognized by DSM-5 as a genetic cause of Autism Spectrum Disorder (ASD), ASD diagnoses remain rare in PWS patients in France, highlighting a critical diagnostic gap. Understanding these distinct profiles is crucial for early, tailored interventions.

The CASSPER study was designed to investigate the specific autistic and sensory profiles present in children diagnosed with Prader-Willi Syndrome. Researchers also aimed to analyze the potential influence of early treatment with oxytocin on the manifestation of these autistic and sensory features. The study's objective is to provide a detailed characterization of these profiles to inform diagnostic practices and intervention strategies, aligning with recommendations for early and personalized care for individuals with PWS.

The provided abstract outlines the aims of the CASSPER study rather than presenting specific findings or numerical results. It states the study's intention to investigate the distinct autistic and sensory profiles in children with Prader-Willi Syndrome and to analyze the potential impact of early oxytocin treatment on these manifestations. No data, statistical values, or specific outcomes from this investigation are reported in the abstract.